Microsurgical intraluminal middle cerebral artery occlusion model in rodents

Acta Neurologica Scandinavica

Volumn 107, Issue 4, 2003, Pages 267-275

  Ardehali, Mohammad Reza ^a,b   Rondouin, G ^a  

^a CNRS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebral ischemia; MCP1; Mice; Middle cerebral artery; MIP1 ; Rats

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NYLON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; EVALUATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROSURGERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; MOTOR DYSFUNCTION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICROSURGERY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0038364015     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00010.x     Document Type: Article

References (39)

1. HUNTER AJ, HATCHER J, VIRLEY D et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000;3:806-16.
2. HUNTER AJ, GREEN AR, CROSS AJ. Animal models of acute ischemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci 1995;16:123-8.
3. WANG CX, YANG T, SHUAIB A. An improved version of embolic model of brain ischemic injury in the rat. J Neurosci Meth 2001;30:147-51.
4. TAMURA A, GRAHAM DI, MCCULLOCH J, TEASDALE GM. Focal cerebral ischemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metabol 1981;1:53-60.
5. BEECH JS, WILLIAMS SCR, CAMPBELL CA et al. Further characterization of a thromboembolic model of stroke in the rat. Brain Res 2001;23:18-24.
6. KILIC E, HERMANN DK, HOSSMANN KA. A reproducible model of thromboembolic stroke in mice. Neuro Report 1998;9:2967-70.
7. WANG CX, YANG Y, YANG T, SHUAIB A. A focal embolic model of cerebral ischemia in rats: introduction and evaluation. Brain Res Brain Res Protoc 2001;7:115-20.
8. ZHANG RL, CHOPP M, ZHANG ZG, JIANG Q, EWING JR. A rat model of focal embolic cerebral ischemia. Brain Res 1997;766:83-92.
9. PUGET A. L'expérimentation animale, son rôle et son apport dans la recherche biomédicale. Paris, France: Centre National de la. Recherche Scientifique (CNRS), Departement des Sciences de la Vie 1997.
10. KOIZUMI J, YOSHIDA Y, NAKAQAWA T, OONEDA G. Experimental studies of ischemic brain edema, I. a new experimental model of cerebral embolism in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986;8:1-8.
11. GARCIA JH, WAGNER S, LIU KF, HU XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 1995;26:627-35.
12. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
13. ZEA LONGA E, WEINSTEIN PR, CARLSON S, CUMMINS R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
14. LAING RJ, JAKUBOWSKI J, LAING RW. Middle cerebral artery occlusion without craniectomy in Rats, which method works best? Stroke 1993;24:294-8.
15. SCHMID-ELSAESSER R, ZAUSINGER S, HUNGERHUBER E, BAETHMANN A, REULEN HJ. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia. Stroke 1998;29:2162-70.
16. KUGE Y, MINEMATSU K, YAMAGUCHI T, MIYAKE Y. Nylon monofilament for intralumunal middle cerebral artery occlusion in rats. Stroke 1995;26:1655-7.
17. ASPEY BS, TAYLOR FL, TERRULI M, HARRISON JG. Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusion. Neuropathol Appl Neurobiol 2000;26:232-42.
18. CLARK WM, LESSOV NS, DIXON MP, ECKENSTEIN F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 1997;19:641-8.
19. BELAYEV L, BUSTO R, ZHAO W, FERNANDEZ G, GINSBERG MD. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological validation. Brain Res 1999;833:181-90.
20. MAO Y, YANG GY, ZHOU LF, STERN JD, BETZ AL. Focal cerebral ischemia in the mouse: description of a model and effects of permanent and temporary occlusion. Mol Brain Res 1999;63:366-70.
21. HOSSMANN KA. Experimental models for the investigation of brain ischemia. Cardiovasc Res 1998;39:106-20.
22. VAN DORSTEN FA, HATA R, MAEDA K et al. Diffusion- and perfusion-weighted MR imaging of transient focal cerebral ischemia in mice. NMR Biomed 1999;12:525-34.
23. CONNOLLY ES, WINFREE CJ, STERN DM, SOLOMON RA, PINSKY DJ. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 1996;38:523-32.
24. BARONE FC, KNUDSEN DJ, NELSON AH, FEUERSTEIN GZ, WILLETTE RN. Mouse strain differences in susceptibility to cerebral ischemia are related to cerebral vascular anatomy. J Cereb Blood Flow Metab 1993;13:683-92.
25. KULUZ JW, GREGORY GA, HAS Y, DIETRICH WD, SCHLEIEN CL. Fructose-1,6-biphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats. Stroke 1993;24:1576-83.
26. ROGERS DC, CAMPBELL CA, STRETTON JL, MACKAY KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997;28:2060-6.
27. TATLISUMAK T, TAKANO K, CARANO RAD, MILLER LP, FOSTER AC, FISHER M. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 1998;29:1952-8.
28. OZDEMIR YG, BOLAY H, ERDEM E, DALKARA T. Occlusion of the MCA by an intraluminal filament may cause disturbances in the hippocampal blood flow due to anomalies of circle of Willis and filament thickness. Brain Res 1999;822:260-4.
29. KAHVECI N, ALKAN T, KORFALI E, OZLUK K. An anatomical and pathological evaluation of middle cerebral artery occlusion in rats. Neurol Res 2000;22:609-14.
30. ASENSIO VC, CAMPBELL IL. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 1999;22:504-12.
31. HAUSMANN EHS, BERMAN NEJ, WANG YY, MEARA JB, WOOD GW, KLEIN RM. Selective chemokine mRNA expression following brain injury. Brain Res 1998;788:49-59.
32. KIM JS, GAUTAM SC, CHOPP M et al. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 1995;56:127-34.
33. WANG X, YUE TL, BARONE FC, FEUERSTEIN GZ. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 1995;26:661-6.
34. HUGHES PM, ALLEGRINI PR, RUDIN M, PERRY VH, MIR AK, WIESSNER C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002;22:308-17.
35. CHE X, YE W, PANGA L, WU DC, YANG GY. Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 2001;902:171-7.
36. TAKAMI S, NISHIKAWA H, MINAMI M et al. Induction of macrophage inflammatory protein MIP-lalpha mRNA on glial cells after focal cerebral ischemia in the rats. Neurosci Lett 1997;277:173-6.
37. GOURMALA NG, LIMONTA S, BOCHELEN D, SAUTER A, BODDEKE HW. Localization of macrophage inflammatory protein: macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience 1999;88:1255-66.
38. COWELL RM, XU H, GALASSO JM, SILVERSTEIN FS. Hypoxic-ischemic injury induces macrophage inflammatory protein-1 alpha expression in immature rat brain. Stroke 2002;33:792-801.
39. PANG L, YE W, CHE XM, ROESSLER BJ, BETZ AL, YANG GY. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-β1 expression. Stroke 2001;32:544-52.